A 3-month comparison of efficacy and safety of brimonidine-tartrate 0.2% timolol 0.5% fixed combination (BID) with timolol 0.5% (BID) or brimonidine-tartrate 0.2% (TID)

被引：0
|
作者：
Craven, ER
Choplin, N
Larsen, C
Olson, M
Whitcup, S
机构：
[1] Glacoma Consultants Colorado, Littleton, CO USA
[2] Eye Care San Diego, San Diego, CA USA
[3] Allergan Pharmaceut Inc, Irvine, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2002年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
282
引用
收藏
页码：U54 / U54
页数：1
相关论文
共 50 条
  • [1] A 3-month comparison of brimonidine-purite 0.15% BID with brimonidine 0.2% BID in patients successfully treated with brimonidine 0.20% BID
    Williams, RD
    Dirks, M
    Batoosingh, AL
    Felix, C
    Whitcup, SM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U55 - U55
  • [2] Effects of Brimonidine 0.2%-Timolol 0.5% Fixed-Combination Therapy for Glaucoma
    Cho, Sung Woo
    Kim, Joon Mo
    Park, Ki Ho
    Choi, Chul Young
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2010, 54 (05) : 407 - 413
  • [3] Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily
    Moisseiev, Elad
    Kurtz, Shimon
    Lazar, Moshe
    Shemesh, Gabi
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1269 - 1273
  • [4] Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma
    Sung Woo Cho
    Joon Mo Kim
    Ki Ho Park
    Chul Young Choi
    Japanese Journal of Ophthalmology, 2010, 54 : 407 - 413
  • [5] Efficacy and safety of combination therapy with brimonidine 0.2% and latanoprost 0.005% versus fixed combination timolol 0.5%/dorzolamide 2%.
    Zabriskie, NA
    Ahmed, IK
    Cantor, LB
    Kent, AB
    Mundorf, T
    Tauber, J
    Rubin, JM
    Hoop, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S833 - S833
  • [6] Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure
    Lee, Anne J.
    McCluskey, Peter
    CLINICAL OPHTHALMOLOGY, 2008, 2 (03): : 545 - 555
  • [7] Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy
    Motolko, Michael A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (09) : 2663 - 2667
  • [8] Suspected granulomatous anterior uveitis associated with brimonidine tartrate 0.2 % and timolol maleate 0.5 % ophthalmic solution
    Alfonso Casado
    Carmen Cabarga
    Miguel A. de la Fuente
    Francisco J. Muñoz-Negrete
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 2659 - 2660
  • [9] Suspected granulomatous anterior uveitis associated with brimonidine tartrate 0.2 % and timolol maleate 0.5 % ophthalmic solution
    Casado, Alfonso
    Cabarga, Carmen
    de la Fuente, Miguel A.
    Munoz-Negrete, Francisco J.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (11) : 2659 - 2660
  • [10] Fixed combination therapy of brimonidine 0.2%-timolol 0.5% versus monotherapy of brimonidine 0.15% among ethnic Koreans
    Kim, Ji Won
    Hong, Samin
    Kim, Chan Yun
    Seong, Gong Je
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
12345